학술논문
Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma.
Document Type
Letter
Author
Source
Subject
*LETTERS to the editor
*RENAL cell carcinoma
*CANCER treatment
*CANCER patients
*
*
*
Language
ISSN
0007-0920
Abstract
A letter to the editor is presented in response to the article "Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib," by F. Di Fiore and colleagues in the 2011 issue.